mesothelioma Cellular Analytics Eyes Early Mesothelioma Detection Using Liquid Biopsy Tech Premium The firm's assay, dubbed MesoFind, uses an immunomagnetic capture method to identify surface antigens on mesothelioma pleural cells in a patient's blood sample. CAR T Cell Therapies Targeting HER2, Mesothelin Show Activity in Solid Tumors Premium In the hunt for an antigen in solid tumors that CAR T cells can target, researchers demonstrate the safety and efficacy profile of two such agents in early studies. MSI Tumor Analysis Implicates Lynch Syndrome in Several New Cancer Types In a pan-cancer analysis, Lynch syndrome genes were mutated more often than anticipated in tumors with high or intermediate levels of microsatellite instability. New Genetic Variant Discovered to Cause Peritoneal Mesothelioma Researchers identified unique ALK rearrangements in patients that lack previously known indicators of mesothelioma. This Week in PNAS: Nov 15, 2016 In PNAS this week: recurrent deletions in mesothelioma patients, mutagenesis screen for genes working with PTEN in triple-negative breast cancer, and more. Dec 18, 2014 Castle's Eye Cancer Test Widely Adopted as Firm Anticipates Growth Beyond Niche Cancer Market Premium Sep 4, 2014 ADRI Begins Phase I Trial of microRNA Mimic for Mesothelioma Premium Aug 13, 2014 Cancer MDx Firm Castle Biosciences Raises $11.8M Oct 5, 2012 Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma Premium Sep 12, 2012 Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test May 10, 2012 Australian Team Finds Blood miRNA with Potential for Early Diagnosis of Malignant Mesothelioma Premium Jun 16, 2011 Rosetta Signs Marketing Deal for Mesothelioma Test with Tort Claims Administration Firm Premium Jun 14, 2011 Rosetta Genomics, Pace Ally on Mesothelioma Test Marketing, Services Apr 8, 2011 NYU, Somalogic Present Data on Protein Biomarker Test for Mesothelioma Premium Dec 30, 2010 CDC Plans $5M for Mesothelioma Biobank Oct 15, 2010 Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma Premium Feb 18, 2010 Q&A: NYU Langone Medical Center's Harvey Pass on miR-29c* and Mesothelioma Prognosis Premium Apr 30, 2009 Three RNAi, miRNA Firms Record Strong Gains in Stock Value Since the End of 2008 Premium Apr 30, 2009 Rosetta, Prometheus Close Deal for miRNA Dx Market Rights Premium Apr 16, 2009 Rosetta Grants Prometheus Rights to Sell Suite of microRNA Diagnostics in US Premium Mar 5, 2009 CombiMatrix Aims to Launch miRNA-Based Cancer Screen by Mid-2010 Premium Breaking News GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing Persephone Biosciences, Janssen Biotech Ink Biomarker Discovery Agreement Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy PhenoTips Raises C$2.5M in Seed Funding Fauna Bio Raises $9M in Seed Money Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test The Scan Two J&J Doses Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports. Pfizer-BioNTech Vaccine Response in Kids The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post. Chicken Changes to Prevent Disease The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics. PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.